Replimune director proposes $694K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Replimune Group, Inc. (REPL) director Veleka Peeples-Dyer reported 34,500 common shares for sale, with an approximate sale date of November 17, 2026, and an aggregate market value of $693,544.50. She acquired those shares from the issuer through a stock option exercise paid in cash on November 17, 2026.
Key Figures
Key Terms
Stock Option Exercise financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.